Brief: Lipigon Pharmaceuticals' Nomination Committee Proposes Lars Öhman As New Chairman
17/05/2022 11:36
May 17 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST :
* NOMINATION COMMITTEE PROPOSES THAT LARS ÖHMAN, A
LONG-STANDING
MEMBER OF THE BOARD OF LIPIGON, BE ELECTED CHAIRMAN OF THE BOARD
OF LIPIGON AT THE ANNUAL GENERAL MEETING
Source text for Eikon: ID:nBQNr2LRF
Further company coverage: LPGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds